Neogen Diagnostics & Poly Clinic Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 27-12-2024
- Paid Up Capital ₹ 2.00 M
as on 27-12-2024
- Company Age 16 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.58 Cr
as on 27-12-2024
- Satisfied Charges ₹ 2.40 M
as on 27-12-2024
- Revenue 23.16%
(FY 2022)
- Profit -76.21%
(FY 2022)
- Ebitda 77.81%
(FY 2022)
- Net Worth 2.49%
(FY 2022)
- Total Assets 23.94%
(FY 2022)
About Neogen Diagnostics & Poly Clinic
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹4.58 Cr. The company has closed loans amounting to ₹2.40 M, as per Ministry of Corporate Affairs (MCA) records.
Abhijit Ray, Md Hossain, and Moumita Ray serve as directors at the Company.
- CIN/LLPIN
U85195WB2008PTC125935
- Company No.
125935
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 May 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Birbhum, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Neogen Diagnostics & Poly Clinic?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhijit Ray  | Director | 22-May-2008 | Current |
| Md Hossain | Director | 22-May-2008 | Current |
| Moumita Ray | Director | 22-May-2008 | Current |
Financial Performance of Neogen Diagnostics & Poly Clinic.
Neogen Diagnostics & Poly Clinic Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 23.16% increase. The company also saw a substantial fall in profitability, with a 76.21% decrease in profit. The company's net worth moved up by a moderate rise of 2.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neogen Diagnostics & Poly Clinic?
In 2022, Neogen Diagnostics & Poly Clinic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Uco Bank Creation Date: 25 Aug 2022 | ₹1.00 Cr | Open |
Hdfc Bank Limited Creation Date: 29 Jul 2022 | ₹1.17 Cr | Open |
Hdfc Bank Limited Creation Date: 29 Jul 2022 | ₹6.07 M | Open |
How Many Employees Work at Neogen Diagnostics & Poly Clinic?
Neogen Diagnostics & Poly Clinic has a workforce of 10 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neogen Diagnostics & Poly Clinic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neogen Diagnostics & Poly Clinic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
